Boxer Capital Management’s Cidara Therapeutics CDTX Stock Holding History

Boxer Capital Management’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-53,000	Closed	-$11.7M	–	55
2025 Q4	$11.7M	Buy	53,000 +5,000	+10%	+$808K	2.56%	12
2025 Q3	$4.6M	Sell	48,000 -7,000	-13%	-$447K	1.47%	17
2025 Q2	$2.68M	Buy	+55,000	New	+$1.32M	1.35%	14

Boxer Capital Management's CDTX Position: Q1 2026 in Review

Boxer Capital Management sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 53,000 shares — an estimated $11.7M sold.

Boxer Capital Management first reported a position in CDTX in Q2 2025 and held it in 3 quarters. The position peaked at $11.7M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Boxer Capital Management reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Boxer Capital Management sold 53,000 Cidara Therapeutics shares in Q1 2026, an estimated $11.7M.
Boxer Capital Management first reported a position in Cidara Therapeutics in Q2 2025 and held it in 3 quarters.
Boxer Capital Management's Cidara Therapeutics position peaked at $11.7M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Boxer Capital Management's 13F filing for Q1 2026, filed 15 May 2026.